The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia-reperfusion injury after lung transplantation
- 31 October 1999
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 118 (4) , 726-732
- https://doi.org/10.1016/s0022-5223(99)70019-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- INHALED NITRIC OXIDE ATTENUATES REPERFUSION INJURY IN NON-HEARTBEATING-DONOR LUNG TRANSPLANTATION1,2Transplantation, 1997
- Nitroprusside Ameliorates Lung Allograft Reperfusion InjuryThe Annals of Thoracic Surgery, 1996
- Cardiac and pulmonary replacement Inhaled nitric oxide improves lung allograft function after prolonged storageThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Inhaled nitric oxide reduces human lung allograft dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant modelThe Journal of Thoracic and Cardiovascular Surgery, 1995
- The Protective Effect of Tetrahydrobiopterin on the Nitric Oxide-Mediated Inhibition of Purified Nitric Oxide SynthaseBiochemical and Biophysical Research Communications, 1995
- Tetrahydrobiopterin as Another EDRF in ManBiochemical and Biophysical Research Communications, 1994
- Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway.Journal of Clinical Investigation, 1994
- Thoracic Intravascular and Extravascular Fluid Volumes in Cardiac Surgical PatientsAnesthesiology, 1993
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980